Folic acid is one of the few supplement ingredients with genuinely strong randomised-trial evidence behind it, and Japan’s regulator has built a fixed, government-approved label sentence specifically because of that evidence. Brands abroad ask for a Japan-made folic acid product for exactly this reason — but the same ingredient carries a real caution that gets left off some labels: high folic acid intake can hide a vitamin B12 problem.
This guide covers what the trial evidence actually shows, what Japan’s Foods with Nutrient Function Claims system permits, and the B12 interaction a formulation should account for.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a folic acid product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
Periconceptional folic acid supplementation reduces the risk of neural tube defects, one of the more consistent and strongly supported findings in supplement research, while separately, high folic acid intake can mask the anaemia of an undiagnosed vitamin B12 deficiency and let its neurological effects progress.
| Study | Design/What was analysed | Reported result |
|---|---|---|
| Cochrane systematic review, 2015 (PMID 26662928) | 5 randomised/quasi-randomised trials, 7,391 women (including a subgroup with a prior neural tube defect pregnancy), periconceptional folic acid versus placebo, no intervention, or micronutrients without folic acid | Neural tube defects reduced, risk ratio 0.31 (95% CI 0.17–0.58) across 6,708 births, graded high-quality evidence; recurrence in women with a prior affected pregnancy also reduced, RR 0.34 (95% CI 0.18–0.64); no clear protective effect shown against other birth defects examined |
| Narrative review, Food and Nutrition Bulletin 2024 (PMID 38987872) | Review of clinical and biochemical evidence on excess folic acid intake alongside vitamin B12 status | High-dose folic acid can relieve the anaemia of B12 deficiency while B12-related neurological damage continues; people with concurrent low B12 and high folate showed worse cognitive outcomes and higher homocysteine and methylmalonic acid than those with low B12 alone; authors describe the evidence as mainly observational but sufficiently compelling to warrant caution |
The neural tube defect evidence is specifically about the periconceptional window — before conception and in early pregnancy — not a general claim about folic acid for the wider population. The B12-masking evidence is not a randomised-trial result; it is drawn from clinical and biochemical observation, and the review itself is honest that the evidence is correlative rather than proven by trial. Both points matter for how a product is worded.
Checked against the published abstracts on 25 September 2026.
What Japanese products say
Japan’s Foods with Nutrient Function Claims (栄養機能食品) system lets a folic acid product carry two fixed sentences once the daily intake amount falls between 72 μg and 200 μg, including a sentence that specifically limits what the fetal-development claim can imply.
Under the Consumer Affairs Agency’s Food Labeling Standards, folic acid qualifies for this labelling route without premarket notification once the stated daily amount sits inside that range. The two permitted function statements (our translation) are:
- “Folic acid is a nutrient that helps in the formation of red blood cells.”
- “Folic acid is a nutrient that contributes to normal fetal development.”
The mandatory caution wording includes the standard “does not cure disease” sentence, plus a caution specific to folic acid (our translation): “Folic acid is a nutrient that contributes to normal fetal development, but taking a larger amount does not improve fetal development.”
Separately from this labelling system, Japan’s health authorities have recommended that women who are planning pregnancy, who may become pregnant, or who are in early pregnancy, aim for an additional 400 μg per day of folic acid from fortified foods or supplements (monoglutamic-acid form) — distinct from ordinary dietary folate — to reduce the risk of neural tube defects, based on the same body of trial evidence summarised above.
Two points for a brand abroad:
- The Japanese nutrient-function wording is deliberately capped. It does not let a product imply that more folic acid means better fetal development — the caution sentence exists to block exactly that reading.
- The 400 μg periconceptional recommendation is a public health target, not the Foods with Nutrient Function Claims range. A product can be formulated to deliver that amount, but the label wording itself follows the nutrient-function system’s own rules and limits.
💬 Need help aligning your folic acid dose with both Japan’s nutrient-function range and a periconceptional target market? We prepare the comparison with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe folic acid by its studied use in the periconceptional period, and never imply that more is better or that it substitutes for B12 status checks.
| Safer wording | Wording to avoid |
|---|---|
| ”Studied for reducing neural tube defect risk when taken before and in early pregnancy" | "Guarantees a healthy pregnancy” or any claim naming a birth defect as something the product prevents in an individual |
| ”Contains folic acid” with the amount per serving, inside Japan’s notified range if using the Japanese wording | Implying that a higher folic acid dose improves fetal development or general health beyond the studied use |
| ”Discuss vitamin B12 status with a healthcare provider before long-term high-dose use” for products aimed at older adults | Silence on B12 in a high-dose folic acid product marketed to groups at higher risk of B12 deficiency |
How folic acid is formulated
Folic acid is water-soluble, stable in its synthetic monoglutamate form, and dosed in micrograms, which is why it fits easily into tablets and combination formulas.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Tablet or capsule | Small, precise dosing, low cost per serving | Straightforward for a single-ingredient product |
| Prenatal multivitamin blend | Common route for a periconceptional target market | Total folic acid across all ingredients in the formula must be tracked, not just the added amount |
| Combination with vitamin B12 | Addresses the masking caution directly | Needs its own amount and stability decisions |
Decisions that shape the specification:
- Amount per serving. For a Japanese Foods with Nutrient Function Claims product, the daily amount must sit between 72 μg and 200 μg. A product targeting the periconceptional 400 μg recommendation needs its own dose decision, separate from the nutrient-function range if that wording is not the goal.
- Folic acid versus food folate. Synthetic folic acid (monoglutamate) and dietary folate (polyglutamate) differ in bioavailability; specify which form the material supplier provides.
- Companion B12. Given the masking evidence above, many folic acid formulas — especially higher-dose ones aimed at older adults — include vitamin B12 as a companion ingredient.
- Your market’s status for folic acid. Fortification and supplement dosing rules for folic acid differ between countries. Confirm the target market’s own upper limit before committing to a dose above Japan’s nutrient-function range.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
Folic acid is a well-established food ingredient in Japan. The formulation risk sits mainly in dose selection and in being clear about the B12 interaction rather than in the ingredient’s basic legal status. See the Japan-made supplement OEM page, and compare with our vitamin B complex and multivitamin guides for how B-vitamin combinations are typically specified.
Before you ask for a quotation
A factory can quote accurately once the folic acid amount, the form, and any B12 companion are fixed.
- Folic acid amount per serving and servings per pack
- Whether you intend to use Japan’s Foods with Nutrient Function Claims wording, and if so, confirmation the amount falls inside 72–200 μg
- Whether the product targets a periconceptional dose (commonly cited at 400 μg) and, if so, how that is labelled outside the Japanese nutrient-function system
- Whether vitamin B12 is included as a companion ingredient
- Countries you will sell in, and folic acid’s status and upper-limit guidance there
💬 Ready to design a Japan-made folic acid product? Send us the concept — amount, form, companion ingredients and the countries you will sell in.
Frequently asked questions
1. Does folic acid really prevent birth defects?
A 2015 Cochrane review of randomised trials found that periconceptional folic acid reduced neural tube defect risk, with high-quality evidence (risk ratio 0.31). This is one of the better-established findings in supplement research, specific to the period before conception and in early pregnancy.
2. What can a Japan-made folic acid product say on its Japanese label?
If the daily amount is between 72 μg and 200 μg, it can carry fixed wording about red blood cell formation and about contributing to normal fetal development, plus a caution stating that a larger amount does not improve fetal development further.
3. Why does folic acid need a B12 caution?
High folic acid intake can correct the anaemia caused by vitamin B12 deficiency while the deficiency’s neurological effects continue untreated, which can delay diagnosis. A 2024 review describes this evidence as mainly observational but compelling enough to warrant caution, particularly for older adults and other groups at higher risk of B12 deficiency.
4. Is the 400 μg periconceptional recommendation the same as Japan’s nutrient-function labelling range?
No. The 400 μg figure is a public health target for women planning pregnancy or in early pregnancy, based on the same trial evidence. Japan’s Foods with Nutrient Function Claims range for folic acid (72–200 μg) is a separate labelling framework with its own fixed wording.
5. Should every folic acid product include vitamin B12?
Not necessarily, but it is a common and reasonable formulation choice given the masking evidence, especially for higher-dose products or ones aimed at older adults.
Sources: “Effects and safety of periconceptional oral folate supplementation for preventing birth defects”, Cochrane Database of Systematic Reviews 2015 (PMID 26662928); “Excess Folic Acid and Vitamin B12 Deficiency: Clinical Implications?”, Food and Nutrition Bulletin 2024;45(1_suppl) (PMID 38987872); hfnet.nibn.go.jp (National Institutes of Biomedical Innovation, Health and Nutrition) for folic acid Foods with Nutrient Function Claims wording, caution statements and lower/upper limits; e-Healthnet (Ministry of Health, Labour and Welfare, kennet.mhlw.go.jp) for the periconceptional 400 μg/day recommendation for women planning or in early pregnancy. Checked on 25 September 2026.